Biopharma Companies Gain Financially Through Unique Targeted Access to the Financial Community
By Pharmatelevision Ltd, PRNESunday, June 6, 2010
OXFORD, England, June 7, 2010 - PharmaTelevision today announced that it is offering pharma and biotech
companies the opportunity to reach key decision makers in the financial
sector.
To celebrate their new relationship with Reuters Insider,
PharmaTelevision(R) is offering companies an opportunity to film, host and
promote their financial or corporate messages between 21-25 June 2010.
Dr Fintan Walton, Chairman of PharmaTelevision, said "When you are
looking to raise funding, communication is the key to winning the deal and
building your business. Our clients benefit from our targeted approach,
identifying the key decision makers from a resource of over 500,000 prospects
through Reuters Insider. PharmaTelevision's Financial Report helps companies
communicate their financial or corporate message - with impact."
Anne Vindenes Allen, Managing Director of PharmaTelevision, said "Our
team of television professionals help companies create top quality
productions that combine video, text and advanced web features. Add to this
PharmaTelevision's power of distribution to top decision makers, and our
ability to syndicate videos to other target audiences, and you have a
formulae to help our industry progress. That's why more companies are now
choosing PharmaTelevision to convey their message."
About Reuters Insider
Reuters Insider is a powerful, internet-based delivery platform that
includes an innovative set of tools that are readily available from any
desktop computer or even on your mobile devices. Reuters Insider also enables
you to easily create and distribute your own proprietary content using little
more than a standard webcam to build your brand within the global financial
community in ways never before possible.
About PharmaTelevision
PharmaTelevision (www.pharmatelevision.com) is produced by
professional television industry experts using professional studios worldwide
as well as its own studios in the UK. PharmaTelevision produces Open Content
as well as subscription based Premium Content.
PharmaTelevision Open Content includes the Regional Report - a programme
that focuses on the key locations for pharmaceutical and biotech investment,
the Financial Report - a programme focused on companies and their performance
and the Business Network - a series of interviews and profiles of some of the
leading companies in biotech.
PharmaTelevision Premium Content includes PharmaTelevision News - a daily
news and analysis programme, PharmaTelevision News Review - a programme
featuring interviews, panel discussions and analysis with leading experts and
leaders in our industry and the Business Report - a programme that analyses
key business and market trends in our industry.
PharmaTelevision(R) is a registered Trade Mark of PharmaVentures Ltd.
Further information on PharmaTelevision's Financial Report, or to book, please contact: Eva Martin on +44(0)1865-332700 or e-mail enquiries@pharmatelevision.com For more information on PharmaTelevision, please contact: Doug Cookson, Commercial Director, PharmaVentures Ltd. +44(0)1865-332-731. doug.cookson@pharmaventures.com
Further information on PharmaTelevision's Financial Report, or to book, please contact: Eva Martin on +44(0)1865-332700 or e-mail enquiries at pharmatelevision.com; For more information on PharmaTelevision, please contact: Doug Cookson, Commercial Director, PharmaVentures Ltd., +44(0)1865-332-731. doug.cookson at pharmaventures.com
Tags: England, June 7, Oxford, Pharmatelevision Ltd, United Kingdom